Female hormones, particularly progesterone and estrogen, can contribute to acid reflux, though the relationship is more layered than a straightforward cause-and-effect. The clearest evidence comes from pregnancy, where surging progesterone relaxes the muscular valve between the esophagus and stomach, and from postmenopausal hormone therapy, where estrogen use raises reflux risk in a dose-dependent way. But at the normal hormonal levels of a typical menstrual cycle, the effect on reflux is surprisingly small, and estrogen appears to play a dual role that can both help and harm the esophagus depending on the context.
How Progesterone Relaxes the Esophageal Valve
The lower esophageal sphincter is a ring of muscle that sits at the junction of the esophagus and stomach. Its job is to open when you swallow and stay closed the rest of the time, preventing stomach acid from washing upward. Progesterone is a smooth-muscle relaxant, and the sphincter is smooth muscle, so the connection seems intuitive. A comprehensive review of progesterone’s effects on the gastrointestinal tract concluded that progesterone reduces esophageal sphincter pressure in a dose-dependent manner, slows overall gut motility, and may support reflux through that mechanism.1PubMed. Impact of progesterone on the gastrointestinal tract: a comprehensive literature review An older but influential study using oral contraceptives found that sphincter pressure dropped significantly when women took a progestin agent alongside estrogen, compared to when they took estrogen alone or no medication at all.2Gastroenterology. Lower Esophageal Sphincter Pressure in Women Using Sequential Oral Contraceptives
This is largely why progesterone has been singled out as the primary hormonal driver of reflux during pregnancy. But the dose matters enormously. The progesterone levels you experience during a normal menstrual cycle are a fraction of what circulates during pregnancy, and that distinction turns out to be critical.
Pregnancy Is the Clearest Case
Heartburn during pregnancy is famously common, affecting the majority of pregnant women at some point, and it is the single strongest illustration of hormones driving acid reflux. A review in the Annals of Internal Medicine concluded that the gastrointestinal changes during pregnancy are caused primarily by hormonal shifts rather than the physical pressure of a growing uterus, with progesterone doing most of the work and estrogen acting as a “primer.”3PubMed. Gastrointestinal motility disorders during pregnancy A separate review in Gastroenterology Clinics of North America agreed, calling the decrease in sphincter pressure from female sex hormones the “predominant factor” and assigning mechanical factors only a small role.4Gastroenterology Clinics of North America. Gastroesophageal Reflux Disease in Pregnancy
Progesterone levels during the third trimester can be ten or more times higher than the peak of a normal menstrual cycle. At those concentrations, the relaxant effect on the sphincter becomes pronounced, gut motility slows, and stomach acid has an easier path upward. The physical displacement of the stomach by the uterus contributes too, but researchers consistently rank it as secondary.
The Menstrual Cycle Puzzle
Given progesterone’s known effect on smooth muscle, you might expect acid reflux to worsen during the second half of the menstrual cycle, when progesterone rises sharply. Some early evidence pointed in that direction. A study measuring sphincter pressure across the cycle found acid reflux in five women during the high-progesterone luteal phase but in only one during the low-progesterone follicular phase.5PubMed. Lower esophageal sphincter pressure during the normal menstrual cycle
However, a more rigorous study using 24-hour acid monitoring found no meaningful difference. Despite large swings in progesterone between the two phases of the cycle, sphincter pressure and the amount of time acid spent in the esophagus were essentially the same, leading the authors to conclude that progesterone at normal physiological concentrations does not predispose healthy women to reflux.6PubMed. Does progesterone fluctuation across the menstrual cycle predispose to gastroesophageal reflux? A separate study measuring hormones alongside objective reflux scores in women similarly found no correlation between hormone levels and standard reflux measures.7PubMed. The role of hormones in symptoms and pathophysiology of reflux and esophageal motility disorders
The takeaway is that the menstrual cycle’s hormonal fluctuations, while real, don’t appear to push acid exposure past a clinically significant threshold in women who don’t already have reflux disease. If you notice more heartburn around your period, hormones alone probably aren’t the full explanation. Weight fluctuation from bloating, changes in diet and stress, or a pre-existing tendency toward reflux may all amplify a small hormonal nudge into noticeable symptoms.
Hormone Replacement Therapy and Reflux Risk
The evidence linking exogenous estrogen to acid reflux is strongest in the context of postmenopausal hormone therapy. A large study of over 50,000 postmenopausal women from the Nurses’ Health Study found that current users of estrogen-only therapy had roughly a 66 percent higher risk of reflux symptoms compared to women who had never used hormones, while current users of combined estrogen and progesterone had about a 41 percent higher risk. The risk climbed with both higher estrogen doses and longer duration of use. Even women taking selective estrogen receptor modulators or over-the-counter hormone products had elevated risk.8PubMed Central. Postmenopausal hormone use and symptoms of gastroesophageal reflux
A study of postmenopausal female twins reached a compatible conclusion: hormone therapy use was associated with reflux symptoms, though oral contraceptive use was not.9PubMed Central. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins The distinction between oral contraceptives and postmenopausal hormone therapy is worth noting. Oral contraceptives are typically taken by younger women with intact estrogen production, so the incremental hormonal load is different from that of an older woman whose baseline estrogen is low.
More recent work has extended these findings to the complications of reflux, not just symptoms. A study examining estrogen-only hormone therapy in postmenopausal women found increased risk of developing not just reflux disease but also Barrett’s esophagus and esophageal stricture, even after accounting for confounders like body weight and smoking. Progesterone-only therapy showed a trend toward increased risk as well, but that finding was not statistically significant, possibly because far fewer women take progesterone alone.10Gastroenterology. Association Between Hormone Replacement Therapy and Gastroesophageal Reflux Disease and Its Complications in Postmenopausal Women
Estrogen’s Dual Role
The hormone therapy data might seem to pin estrogen as straightforwardly harmful to the esophagus, but the picture is more complicated. Animal research has shown that estradiol relaxes lower esophageal sphincter muscle strips in a dose-dependent fashion, working through a specific receptor found in sphincter tissue.11PubMed. Estradiol mediates relaxation of porcine lower esophageal sphincter That relaxation effect could promote reflux.
At the same time, laboratory work on esophageal tissue suggests estrogen strengthens the esophageal lining itself. In one study, estradiol treatment significantly reduced the damage caused by acid exposure by boosting the expression of a tight-junction protein that holds cells together, keeping the barrier intact. The dilation of spaces between esophageal cells, a hallmark of acid-damaged tissue, was significantly reduced by estradiol.12SpringerLink / PubMed Central. Estrogen Enhances Esophageal Barrier Function by Potentiating Occludin Expression
So estrogen may simultaneously make it easier for acid to reach the esophagus (by relaxing the valve) and harder for that acid to damage the tissue once it arrives (by reinforcing the barrier). This paradox might partly explain why women of reproductive age tend to have lower rates of the more severe, tissue-damaging form of reflux disease than men, even when they report reflux symptoms at comparable or higher rates. One large study found that erosive esophagitis, the kind where acid has visibly damaged the lining, occurred at a rate of about 11 percent in men but only about 2 percent in women, while the non-erosive form was actually more common in women.13PubMed Central. Gender-specific Effect of Micronutrient on Non-erosive Reflux Disease and Erosive Esophagitis
Why Menopause Brings More Reflux
If estrogen protects the esophageal lining, it stands to reason that losing estrogen at menopause would leave the esophagus more vulnerable. And that is largely what the data show. A study of perimenopausal and menopausal women found that menopausal women were about three times more likely to report reflux symptoms than premenopausal women, with nearly half of menopausal participants reporting upper GI complaints. Strikingly, about 80 percent of the symptomatic women in that study had never been formally diagnosed with any upper GI disorder.14PubMed. The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal women
Endoscopy-based research has confirmed a similar pattern: the incidence of reflux esophagitis rises sharply in women after age 50, a timeline that maps closely onto menopause. During reproductive years, women have lower rates of the reflux spectrum than men, but that gap narrows or reverses after menopause.15PubMed Central. Sex and Gender Differences in Gastroesophageal Reflux Disease
This creates an apparent contradiction with the hormone therapy findings. If low estrogen after menopause makes reflux worse, why does taking estrogen to replace it also make reflux worse? One possibility is that exogenous estrogen behaves differently from the estrogen your body produces naturally, perhaps because of how oral estrogen is metabolized through the liver, or because hormone therapy introduces steady-state levels rather than the fluctuating patterns of natural production. Another possibility is that the increased body weight often associated with hormone therapy use mediates part of the risk. The honest answer is that researchers have not fully untangled this paradox.
Pain Perception and How Hormones Shape Symptoms
Hormones don’t just affect the mechanics of reflux. They also change how you feel it. Estrogen and progesterone both influence pain processing in the nervous system, and testosterone appears to blunt pain sensitivity. A study of sex- and gender-specific differences in reflux symptoms noted that women with low estrogen levels tend to have higher pain sensitivity, which may explain why postmenopausal women report more severe symptoms. Men’s higher testosterone levels, by contrast, may act as a protective factor against reflux-related pain.16Diseases of the Esophagus. Sex- and gender-specific differences in symptoms and health-related quality of life among patients with gastroesophageal reflux disease
This matters for interpretation because most reflux studies rely on symptom questionnaires. If hormonal changes make you more sensitive to the discomfort of acid in the esophagus, your reflux symptoms may worsen even if the amount of acid exposure hasn’t actually changed. A woman experiencing the same degree of acid contact as a man might report more severe heartburn simply because her nervous system processes the sensation differently. This is not imaginary pain; it is a real difference in sensory processing driven by biology.
The practical implication is that worsening reflux symptoms around hormonal transitions, whether during menstrual phases, perimenopause, or after starting hormone therapy, may sometimes reflect altered pain perception rather than increased acid. Standard reflux treatments like proton pump inhibitors address acid production, but they won’t fully relieve symptoms that are partly driven by heightened nerve sensitivity. If your heartburn doesn’t respond well to acid-reducing medication, the sensory component is worth discussing with your doctor.
Hormonal Conditions and Gut Symptoms
Conditions that alter the hormonal landscape can also affect reflux indirectly. A large nationwide cohort study comparing women with polycystic ovary syndrome and endometriosis found that PCOS in particular was associated with a broader range of symptoms, including gastrointestinal problems, beyond what would be explained by the reproductive symptoms alone.17Journal of Korean Medical Science. Similar but Distinct Comorbidity Patterns Between Polycystic Ovary Syndrome and Endometriosis in Korean Women: A Nationwide Cohort Study PCOS involves elevated androgens and often insulin resistance, both of which can contribute to weight gain, a well-established reflux risk factor. Disentangling the hormonal effect from the metabolic one is difficult, but the association suggests that women with hormonal disorders should be aware of a potentially higher baseline risk for digestive complaints, including reflux.
Endometriosis, meanwhile, is driven by estrogen and primarily manifests as pain-related symptoms. While it does not have the same broad GI profile as PCOS, the chronic inflammation and pain processing changes associated with it can overlap with reflux-like symptoms, sometimes leading to misdiagnosis in either direction.
What This Means If You’re Managing Reflux
If you’re a woman dealing with reflux that seems to shift with hormonal changes, the evidence supports taking that connection seriously, even though the mechanism is not as simple as “more progesterone equals more heartburn.” A few practical points follow from the research:
- Pregnancy reflux is real and hormone-driven: Lifestyle modifications and medications deemed safe in pregnancy are the standard approach. The reflux almost always resolves after delivery when hormone levels drop.
- Hormone therapy decisions should factor in reflux: If you’re on or considering postmenopausal hormone therapy and have troublesome reflux, the risk increase is meaningful. The Nurses’ Health Study data showed a clear dose-response relationship, meaning a lower dose may carry less reflux risk.8PubMed Central. Postmenopausal hormone use and symptoms of gastroesophageal reflux
- Menstrual-cycle reflux likely has multiple contributors: Objective studies haven’t confirmed that normal progesterone fluctuations alone drive clinically significant reflux, so blaming hormones exclusively may cause you to overlook triggers like diet, stress, or sleep position that are easier to address.
- Perimenopause and menopause deserve screening: Given that most symptomatic women in the menopausal studies had never been diagnosed, reflux in this group appears to be substantially underrecognized. If you’re experiencing new or worsening upper GI symptoms around menopause, it is worth raising with your healthcare provider rather than assuming it’s a normal part of aging.
The Gap Between Symptoms and Tissue Damage
One of the more interesting patterns in this research is the divergence between how reflux feels and what it does to tissue. Women of reproductive age tend to report more non-erosive reflux disease, where symptoms are present but the esophageal lining looks normal on endoscopy. Men, meanwhile, are more likely to have erosive disease and Barrett’s esophagus, a precancerous tissue change. After menopause, women’s rates of erosive disease begin to climb.15PubMed Central. Sex and Gender Differences in Gastroesophageal Reflux Disease
The estrogen barrier-protection findings offer a plausible explanation. If estrogen helps hold esophageal cells together and limit acid penetration, premenopausal women may tolerate a certain amount of acid exposure without visible tissue damage. Remove that protection at menopause, and the same acid exposure starts causing erosion. This also helps explain the paradox that premenopausal women report plenty of reflux symptoms but show less tissue injury: their esophagus may be better armored, even if their nervous system is more attuned to the discomfort.
For women approaching or past menopause, the practical relevance is that reflux symptoms may carry more tissue-level risk than they once did. A woman who lived comfortably with occasional heartburn in her 30s and 40s may want to reassess that tolerance in her 50s, when the protective hormonal buffer has receded and the same symptoms could indicate more significant acid damage.